DK1295129T3 - Differentialdiagnose af neurologiske sygdomme - Google Patents

Differentialdiagnose af neurologiske sygdomme

Info

Publication number
DK1295129T3
DK1295129T3 DK01957875.6T DK01957875T DK1295129T3 DK 1295129 T3 DK1295129 T3 DK 1295129T3 DK 01957875 T DK01957875 T DK 01957875T DK 1295129 T3 DK1295129 T3 DK 1295129T3
Authority
DK
Denmark
Prior art keywords
individual suffering
versus
differential diagnosis
disease
neurological diseases
Prior art date
Application number
DK01957875.6T
Other languages
English (en)
Inventor
Frank Hulstaert
Eugeen Vanmechelen
Hugo Vanderstichele
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Application granted granted Critical
Publication of DK1295129T3 publication Critical patent/DK1295129T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK01957875.6T 2000-06-30 2001-06-21 Differentialdiagnose af neurologiske sygdomme DK1295129T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00870151 2000-06-30
US21890700P 2000-07-18 2000-07-18
PCT/EP2001/007029 WO2002003073A1 (en) 2000-06-30 2001-06-21 Differential diagnosis of neurological diseases

Publications (1)

Publication Number Publication Date
DK1295129T3 true DK1295129T3 (da) 2010-07-12

Family

ID=45540530

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01957875.6T DK1295129T3 (da) 2000-06-30 2001-06-21 Differentialdiagnose af neurologiske sygdomme

Country Status (11)

Country Link
EP (1) EP1295129B1 (da)
JP (1) JP4851052B2 (da)
AT (1) ATE463745T1 (da)
AU (2) AU7967801A (da)
CA (1) CA2411584C (da)
DE (1) DE1295129T1 (da)
DK (1) DK1295129T3 (da)
ES (1) ES2343510T3 (da)
PT (1) PT1295129E (da)
SI (1) SI1295129T1 (da)
WO (1) WO2002003073A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1583503A4 (en) * 2002-12-20 2006-08-09 Biogen Idec Inc POLYVALENT LYMPHOTOXIN BETA RECEPTOR AGONISTS AND THERAPEUTIC USE THEREOF
US8506933B2 (en) 2007-11-30 2013-08-13 Msdx, Inc. Methods of detecting a neurological condition via analysis of circulating phagocytes
US8673309B2 (en) 2011-02-11 2014-03-18 Msdx, Inc. Methods for measuring high molecular weight complexes of fibrinogen with fibronectin and fibulin-1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733734A (en) * 1991-08-14 1998-03-31 The Trustees Of The University Of Pennsylvania Method of screening for Alzheimer's disease or disease associated with the accumulation of paired helical filaments
JPH07132033A (ja) * 1993-11-12 1995-05-23 Hoechst Japan Ltd アルツハイマー病モデルトランスジェニック動物
CA2178212C (en) * 1993-12-21 2011-06-14 Marc Vandermeeren Monoclonal antibodies specific for phf-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications
JP2000253774A (ja) * 1999-03-12 2000-09-19 Mitsubishi Chemicals Corp タウ蛋白のリン酸化が亢進された実験用マウス

Also Published As

Publication number Publication date
ES2343510T3 (es) 2010-08-03
SI1295129T1 (sl) 2010-08-31
EP1295129A1 (en) 2003-03-26
EP1295129B1 (en) 2010-04-07
CA2411584C (en) 2012-07-24
AU2001279678B2 (en) 2005-08-18
JP2004502939A (ja) 2004-01-29
WO2002003073A1 (en) 2002-01-10
DE1295129T1 (de) 2003-06-26
CA2411584A1 (en) 2002-01-10
AU7967801A (en) 2002-01-14
JP4851052B2 (ja) 2012-01-11
PT1295129E (pt) 2010-06-21
ATE463745T1 (de) 2010-04-15

Similar Documents

Publication Publication Date Title
CY1110195T1 (el) Διαφορικη διαγνωση νευρολογικων νοσων
JO2359B1 (en) Benzathene derivatives as agents for modulation of GABA A receptor
ATE540678T1 (de) Prodrugs aus gaba-analoga, zusammensetzungen und ihre verwendungen
BR0115482A (pt) Composição de sacralose melhorada e processo para sua preparação
BG66103B1 (bg) Кондензирани пиролокарбазоли
ATE463247T1 (de) Bupropion metaboliten zur behandlung von angstzuständen
BR0011448A (pt) Imidazoquinolinas substituìdas por amida
ATE492279T1 (de) Bupropinmetaboliten zur behandlung von dementia und anderen zerebrovasckulären erkrankungen
IL146631A0 (en) Diagnostics and therapeutics for cardiovascular disorders
NO20026263L (no) Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
PT1224205E (pt) Derivados 5-beta-sapogenina e pseudo-sapogenina e sua utilizacao no tratamento de demencia
WO2004024074A3 (en) Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulators
DE60108042D1 (de) Prozesse zur Herstellung von pulverförmigen Schlagzäh-Modifizierern
MY124786A (en) Bis-arylsulfones
DE60227517D1 (de) Verfahren zur herstellung von 10,11 dihydro 10 hydroxy 5h-dibenz/b,f/azepin-5-carbonsäureamid und 10,11 dihydro 10 oxo-5h-dibenz/b,f/azepin-5 carbonsäureamid
DK1295129T3 (da) Differentialdiagnose af neurologiske sygdomme
IL142803A0 (en) Pharmaceutical compositions containing r-tofisopam
ATE365036T1 (de) Creatinester-pronutrient-verbindungen und formulierungen
TWI245756B (en) Improved process for the preparation of 1,3-substituted indenes
BRPI0408077A (pt) composições e métodos para prevenção e tratamento de doenças relacionadas com endotoxina e condições
ATE345818T1 (de) S-methyl-dihydro-ziprasidone zur behandlung von psychiatrischen störungen.
DE60220800D1 (de) Chirales dinapsolin
TW200500350A (en) Photochromic oxazine compounds and methods for their manufacture
BG105247A (en) N-substituted azabicycloheptane derivatives, production and use thereof
TW200420286A (en) Improved process for the preparation of aryl fused polycyclic lactams